We stained the lung adenocarcinoma TMA with antibodies against an EMT marker (E-cadherin 1 (CDH1), molecules included in the signature (SMAD7, PLAUR), and immune checkpoint markers. The gene discussed is CDH1; the disease is lung adenocarcinoma.